Enyue Fang, Guodan He, Yutong Chang, Qijia He, Pan Chen, Kongxin Hu
{"title":"Application Advances of Lentiviral Vectors: From Gene Therapy to Vaccine Development.","authors":"Enyue Fang, Guodan He, Yutong Chang, Qijia He, Pan Chen, Kongxin Hu","doi":"10.1007/s12033-025-01472-y","DOIUrl":null,"url":null,"abstract":"<p><p>Since their development in the 1990s, the applications of lentiviral vectors have rapidly extended to the fields of gene and cancer therapy, as well as vaccine development, owing to their unique advantages of efficiently transducing both dividing and nondividing cells and achieving stable and long-term expression of genes. However, with their clinical application, potential safety issues have emerged, such as the possibility of insertional oncogenesis, immune reactions, and tumorigenesis, which have attracted widespread attention from the academic and clinical communities. In this review, we thoroughly explore the strategies used to optimize lentiviral vectors and assess their potential benefits and risks in different fields. We summarize the latest research on the use of lentiviral vectors, covering their development, classification, and applications in cancer therapy, treatment of genetic diseases, and vaccine development, as well as discussing important safety considerations. This review acts as an informative reference for academics and clinicians, providing insights into the potential future research directions and possible clinical applications of lentiviral vectors. We hope that this review will promote the continuous improvement of lentiviral vector technology and realize its full therapeutic potential in the treatment and prevention of diseases.</p>","PeriodicalId":18865,"journal":{"name":"Molecular Biotechnology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12033-025-01472-y","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Since their development in the 1990s, the applications of lentiviral vectors have rapidly extended to the fields of gene and cancer therapy, as well as vaccine development, owing to their unique advantages of efficiently transducing both dividing and nondividing cells and achieving stable and long-term expression of genes. However, with their clinical application, potential safety issues have emerged, such as the possibility of insertional oncogenesis, immune reactions, and tumorigenesis, which have attracted widespread attention from the academic and clinical communities. In this review, we thoroughly explore the strategies used to optimize lentiviral vectors and assess their potential benefits and risks in different fields. We summarize the latest research on the use of lentiviral vectors, covering their development, classification, and applications in cancer therapy, treatment of genetic diseases, and vaccine development, as well as discussing important safety considerations. This review acts as an informative reference for academics and clinicians, providing insights into the potential future research directions and possible clinical applications of lentiviral vectors. We hope that this review will promote the continuous improvement of lentiviral vector technology and realize its full therapeutic potential in the treatment and prevention of diseases.
期刊介绍:
Molecular Biotechnology publishes original research papers on the application of molecular biology to both basic and applied research in the field of biotechnology. Particular areas of interest include the following: stability and expression of cloned gene products, cell transformation, gene cloning systems and the production of recombinant proteins, protein purification and analysis, transgenic species, developmental biology, mutation analysis, the applications of DNA fingerprinting, RNA interference, and PCR technology, microarray technology, proteomics, mass spectrometry, bioinformatics, plant molecular biology, microbial genetics, gene probes and the diagnosis of disease, pharmaceutical and health care products, therapeutic agents, vaccines, gene targeting, gene therapy, stem cell technology and tissue engineering, antisense technology, protein engineering and enzyme technology, monoclonal antibodies, glycobiology and glycomics, and agricultural biotechnology.